Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 181: Toxicity of ethanol is due to:

A. Increased NADH/NAD+ ratio (Correct Answer)
B. Decreased lactate/pyruvate ratio
C. Inhibition of gluconeogenesis
D. Stimulation of fatty acid oxidation

Explanation: The metabolism of ethanol primarily occurs in the liver via two steps catalyzed by **Alcohol Dehydrogenase (ADH)** and **Acetaldehyde Dehydrogenase (ALDH)**. Both reactions reduce NAD+ to NADH, leading to a significantly **increased NADH/NAD+ ratio**. This redox imbalance is the fundamental biochemical driver of ethanol toxicity. ### Why Option A is Correct: The excess NADH shifts the equilibrium of several key metabolic pathways: * **Pyruvate to Lactate:** To regenerate NAD+, the body converts pyruvate to lactate (via LDH), leading to lactic acidosis. * **Oxaloacetate to Malate:** High NADH pushes OAA toward malate, depleting the substrate needed for gluconeogenesis. * **DHAP to Glycerol-3-Phosphate:** This provides the backbone for triglyceride synthesis, contributing to fatty liver. ### Why Other Options are Incorrect: * **B. Decreased lactate/pyruvate ratio:** Incorrect. The high NADH/NAD+ ratio actually **increases** the lactate/pyruvate ratio, leading to hyperlactatemia. * **C. Inhibition of gluconeogenesis:** While ethanol *does* inhibit gluconeogenesis (leading to fasting hypoglycemia), this is a **consequence** of the increased NADH/NAD+ ratio, not the primary cause of toxicity itself. * **D. Stimulation of fatty acid oxidation:** Incorrect. High NADH levels **inhibit** β-oxidation of fatty acids and instead stimulate fatty acid synthesis, leading to steatosis (fatty liver). ### High-Yield NEET-PG Pearls: * **Disulfiram** inhibits ALDH, causing acetaldehyde accumulation (the "hangover" toxin). * **Fomepizole** inhibits ADH and is used as an antidote for methanol/ethylene glycol poisoning. * **Metabolic Triad of Ethanol:** Hypoglycemia, Lactic Acidosis, and Ketoacidosis. * **Chronic Alcoholism:** Often associated with **Thiamine (B1) deficiency** because ethanol inhibits its absorption, leading to Wernicke-Korsakoff syndrome.

Question 182: What is considered good diabetic control when assessing glycosylated haemoglobin levels?

A. 7-9% (Correct Answer)
B. >13%
C. 10-12%
D. 3-4%

Explanation: **Explanation:** Glycosylated hemoglobin (HbA1c) reflects the average blood glucose concentration over the preceding 8–12 weeks (the lifespan of an erythrocyte). It is formed by the non-enzymatic attachment of glucose to the N-terminal valine of the beta chain of hemoglobin. **Why Option A is Correct:** In clinical practice, for a patient already diagnosed with Diabetes Mellitus, an HbA1c level of **7–9%** is traditionally categorized as **"Good Control."** While modern guidelines (like the ADA) often aim for <7% to prevent microvascular complications, in the context of standard medical examinations like NEET-PG, the grading is typically: * **<7%:** Excellent control * **7–9%:** Good/Fair control * **>10%:** Poor control **Analysis of Incorrect Options:** * **Option B (>13%):** Represents very poor glycemic control, indicating a high risk of acute and chronic complications (e.g., ketoacidosis, retinopathy). * **Option C (10–12%):** Indicates poor diabetic control, necessitating an immediate change in treatment or lifestyle. * **Option D (3–4%):** This is below the normal physiological range for healthy individuals (normal is typically 4–5.6%). Such low levels are not a target for diabetics as they would imply frequent, dangerous hypoglycemic episodes. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Cut-off:** According to the WHO/ADA, an HbA1c **≥ 6.5%** is diagnostic for Diabetes Mellitus. * **Pre-diabetes:** HbA1c levels between **5.7% and 6.4%**. * **False Lows:** HbA1c can be falsely low in conditions with high red cell turnover, such as **hemolytic anemia** or recent blood loss. * **False Highs:** HbA1c can be falsely elevated in **iron deficiency anemia** (due to increased erythrocyte lifespan). * **Measurement:** It is measured using Ion-exchange chromatography or HPLC (Gold Standard).

Question 183: Bilirubin is absent in urine because it is:

A. Distributed in the body fat
B. Conjugated with glucuronide
C. Not filterable
D. Lipophilic (Correct Answer)

Explanation: **Explanation:** The question refers to **unconjugated bilirubin (UCB)**, which is the form of bilirubin normally present in the blood before it reaches the liver. **1. Why "Lipophilic" is correct:** Unconjugated bilirubin is a **lipophilic (fat-soluble)** and hydrophobic molecule. Because it does not dissolve in water, it cannot travel freely in the plasma; instead, it must be tightly bound to **albumin**. This albumin-bilirubin complex is too large to pass through the glomerular basement membrane of the kidney. Therefore, unconjugated bilirubin is **not filtered** into the urine. In healthy individuals, the absence of bilirubin in urine is due to its lipophilic nature and subsequent protein binding. **2. Analysis of Incorrect Options:** * **A. Distributed in body fat:** While lipophilic, UCB primarily binds to albumin in the blood. It only deposits in fat/tissues (like the brain in kernicterus) when levels exceed albumin-binding capacity. * **B. Conjugated with glucuronide:** This is incorrect because **conjugated bilirubin** is water-soluble (hydrophilic). If bilirubin were conjugated, it *would* be filtered by the kidney and appear in the urine (as seen in obstructive jaundice). * **C. Not filterable:** While technically true that the albumin-UCB complex is not filterable, "Lipophilic" is the more fundamental biochemical reason *why* it requires a carrier protein that prevents filtration. **Clinical Pearls for NEET-PG:** * **Acholuric Jaundice:** This term refers to hemolytic jaundice where unconjugated bilirubin is high. Since UCB cannot enter urine, the urine remains normal in color (no "bilirubinuria"). * **Bilirubinuria:** Always indicates **conjugated hyperbilirubinemia** (e.g., biliary obstruction or hepatitis), as only water-soluble conjugated bilirubin can pass into the urine. * **Van den Bergh Reaction:** Unconjugated bilirubin gives an **indirect** positive result, while conjugated bilirubin gives a **direct** positive result.

Question 184: Which of the following conditions can lead to a falsely elevated HbA1c?

A. Thalassemia
B. Recovery from acute blood loss
C. Erythropoietin supplementation in CKD
D. Splenectomy (Correct Answer)

Explanation: **Explanation:** The HbA1c level reflects the average blood glucose over the preceding 8–12 weeks. It is dependent on the **lifespan of the erythrocyte**. Any condition that increases the average age of the red blood cell (RBC) population will lead to a **falsely elevated HbA1c**, as the hemoglobin is exposed to glucose for a longer duration. **Why Splenectomy is correct:** The spleen is responsible for sequestering and destroying aged or damaged RBCs. Following a **splenectomy**, RBC survival is prolonged. These "older" cells remain in circulation longer, accumulating more glycation over time, which results in a falsely high HbA1c reading despite normal glycemic control. **Why the other options are incorrect:** * **Thalassemia:** Generally leads to **falsely low** HbA1c due to increased RBC turnover (hemolysis) and the presence of abnormal hemoglobin variants that may interfere with standard assays. * **Recovery from acute blood loss:** During recovery, the bone marrow releases a surge of reticulocytes (young RBCs). A younger cell population has had less time for glycation, leading to a **falsely low** HbA1c. * **Erythropoietin (EPO) supplementation:** EPO stimulates the production of new RBCs. Similar to blood loss recovery, the influx of young erythrocytes decreases the average age of the RBC pool, resulting in a **falsely low** HbA1c. **NEET-PG High-Yield Pearls:** * **Falsely High HbA1c:** Iron deficiency anemia (most common cause), Splenectomy, Vitamin B12/Folate deficiency (delayed RBC maturation). * **Falsely Low HbA1c:** Hemolytic anemias, Chronic Kidney Disease (reduced RBC lifespan), Pregnancy (increased RBC turnover), and recent blood transfusions. * **Alternative:** In patients with altered RBC lifespans, **Fructosamine** (reflecting 2–3 weeks) or **Glycated Albumin** should be used for glycemic monitoring.

Question 185: Which enzyme is typically elevated in myopathies?

A. Creatine phosphokinase (CPK) (Correct Answer)
B. Serum glutamic-oxaloacetic transaminase (SGOT)
C. Serum glutamic-pyruvic transaminase (SGPT)
D. Aspartate aminotransferase (AST)

Explanation: **Explanation:** **Creatine Phosphokinase (CPK)**, also known as Creatine Kinase (CK), is the most sensitive and specific enzyme marker for muscle damage. It catalyzes the reversible conversion of creatine and ATP to phosphocreatine and ADP. In myopathies (diseases of the muscle tissue), the integrity of the muscle cell membrane (sarcolemma) is compromised, leading to the leakage of intracellular enzymes into the bloodstream. Specifically, the **CK-MM isoenzyme** is found predominantly in skeletal muscle, making total CPK levels significantly elevated in conditions like Duchenne Muscular Dystrophy, polymyositis, and rhabdomyolysis. **Analysis of Incorrect Options:** * **SGOT (Serum Glutamic-Oxaloacetic Transaminase) / AST (Aspartate Aminotransferase):** These are the same enzyme (AST is the modern name). While AST is found in muscle and can be elevated in myopathies, it is much less specific than CPK as it is also highly concentrated in the liver and heart. * **SGPT (Serum Glutamic-Pyruvic Transaminase) / ALT:** This enzyme is primarily a marker for **hepatocellular injury** (liver damage). While trace amounts exist in muscle, it is not a diagnostic marker for myopathies. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** CPK is the first enzyme to rise in muscle injury. * **Isoenzymes:** Remember the "Rule of Three": **CK-MM** (Skeletal muscle), **CK-MB** (Cardiac muscle), and **CK-BB** (Brain/Smooth muscle). * **Aldolase:** Another enzyme elevated in myopathies, often used if CPK results are inconclusive. * **DMD:** In Duchenne Muscular Dystrophy, CPK levels can be 50–100 times the upper limit of normal even before clinical symptoms appear.

Question 186: Microalbuminuria is defined as the amount of albumin passing in urine per 24 hours, measured in milligrams.

A. 30-299 mg
B. 30-300 mg (Correct Answer)
C. 400-400 mg
D. 800-1200 mg

Explanation: **Explanation:** **Microalbuminuria** is a critical clinical marker used to detect early-stage diabetic nephropathy and assess cardiovascular risk. It refers to a level of albumin excretion that is higher than normal but below the detection limit of a standard urine dipstick (which typically only detects levels >300 mg/day). 1. **Why Option B is Correct:** According to the American Diabetes Association (ADA) and KDIGO guidelines, microalbuminuria is defined as the excretion of **30–300 mg of albumin in a 24-hour urine collection**. * **Normal (Normoalbuminuria):** <30 mg/24 hours. * **Microalbuminuria:** 30–300 mg/24 hours. * **Macroalbuminuria (Overt Nephropathy):** >300 mg/24 hours. 2. **Analysis of Incorrect Options:** * **Option A (30-299 mg):** While technically close, the standard clinical threshold for "Overt Proteinuria" begins at 300 mg and above; therefore, 300 mg is traditionally included in the upper limit of the microalbuminuria range in most textbook definitions. * **Options C & D:** These values (400 mg and above) fall into the category of **Macroalbuminuria** or clinical proteinuria, indicating established glomerular damage. **High-Yield Clinical Pearls for NEET-PG:** * **ACR (Albumin-to-Creatinine Ratio):** Since 24-hour collection is cumbersome, a "spot" morning urine sample is often used. Microalbuminuria is defined as an ACR of **30–300 mg/g**. * **Screening:** In Type 2 Diabetes, screen at the time of diagnosis. In Type 1 Diabetes, screen 5 years after diagnosis. * **Reversibility:** This stage is significant because it is potentially reversible with strict glycemic control and the use of ACE inhibitors or ARBs.

Question 187: Regarding liver enzymes, which of the following statements is true?

A. ALT is less specific than AST.
B. Absolute levels of enzyme markers correlate with outcome.
C. Glutathione-s-transferase is used as a hepatic prognostic marker following surgery. (Correct Answer)
D. None of the above.

Explanation: ### Explanation **Correct Answer: C. Glutathione-s-transferase is used as a hepatic prognostic marker following surgery.** **Why it is correct:** Glutathione-S-transferase (GST), specifically the alpha-isoenzyme (α-GST), is a highly sensitive marker for acute hepatocellular damage. Unlike ALT and AST, which are concentrated in specific zones of the liver lobule, GST is distributed uniformly throughout the liver. It has a very short half-life (less than 90 minutes), making it an excellent **real-time prognostic marker**. In clinical practice, it is used to monitor liver integrity post-transplantation or major hepatic surgery; a rapid decline indicates successful recovery, while persistent elevation suggests ongoing graft rejection or ischemic injury. **Why other options are incorrect:** * **Option A:** **ALT (Alanine Aminotransferase)** is actually **more specific** for the liver than AST. AST (Aspartate Aminotransferase) is found in significant quantities in the heart, skeletal muscle, kidneys, and RBCs, leading to elevations in myocardial infarction or hemolysis. * **Option B:** Absolute levels of enzymes (ALT/AST) generally reflect the **acuteness and extent** of hepatocyte injury, but they **do not correlate with prognosis or liver function**. For example, in fulminant hepatic failure, enzyme levels may actually drop (the "pseudo-normalization" phenomenon) because there are no viable hepatocytes left to release them. **High-Yield Clinical Pearls for NEET-PG:** * **De Ritis Ratio (AST/ALT):** If >2, it suggests Alcoholic Liver Disease; if <1, it suggests Viral Hepatitis. * **Shortest Half-life:** GST has a shorter half-life than ALT (~47 hours) or AST (~17 hours), making it superior for monitoring acute changes. * **Zone 3 Sensitivity:** Centrilobular (Zone 3) hepatocytes are most susceptible to ischemic injury; GST is a sensitive indicator of this damage.

Question 188: Which of the following is the most appropriate diagnostic test for pancreatic insufficiency?

A. Schilling test
B. Serum lipase
C. Serum amylase
D. Faecal fat estimation (Correct Answer)

Explanation: **Explanation:** **Pancreatic insufficiency** occurs when the exocrine pancreas fails to produce or secrete adequate digestive enzymes (lipase, protease, amylase), leading to malabsorption. Since dietary fats require pancreatic lipase for digestion, fat malabsorption is the hallmark of this condition. **Why Faecal Fat Estimation is Correct:** The **72-hour faecal fat estimation** is the gold standard for diagnosing and quantifying steatorrhea (excess fat in stools). It directly measures the functional consequence of lipase deficiency. A fat excretion of >7 grams/day (while on a 100g fat diet) confirms malabsorption, making it the most appropriate diagnostic test among the given options. **Analysis of Incorrect Options:** * **A. Schilling Test:** Historically used to diagnose Vitamin B12 malabsorption (Pernicious anemia vs. ileal disease). While pancreatic enzymes are needed to cleave R-binders from B12, it is not the primary test for pancreatic function. * **B & C. Serum Lipase and Amylase:** These are markers of **acute pancreatic injury** (Acute Pancreatitis). In chronic pancreatic insufficiency, these enzymes are often normal or even low due to the destruction of acinar tissue. They are not used to assess functional insufficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Most Sensitive Non-invasive Test:** Faecal Elastase-1 (more specific and easier than 72-hour fat collection). * **Gold Standard (Invasive):** Secretin-Cholecystokinin (CCK) stimulation test. * **Classic Triad of Chronic Pancreatitis:** Steatorrhea, Diabetes Mellitus, and Pancreatic Calcification. * **D-Xylose Test:** Used to differentiate mucosal malabsorption (e.g., Celiac disease) from pancreatic insufficiency (D-xylose absorption is normal in pancreatic disease).

Question 189: In non-hemolytic jaundice, which of the following conditions is associated with elevated levels of urobilinogen?

A. Obstructive jaundice
B. Hepatic fibrosis
C. Fatty liver
D. Infective hepatitis (Correct Answer)

Explanation: **Explanation:** In **Infective Hepatitis** (Hepatocellular Jaundice), there is damage to the hepatocytes. While the liver can still conjugate some bilirubin, the damaged cells are unable to efficiently re-excrete the recirculated **urobilinogen** (which returns from the gut via enterohepatic circulation) back into the bile. Consequently, this urobilinogen spills into the systemic circulation and is excreted by the kidneys, leading to **elevated urinary urobilinogen**. **Analysis of Options:** * **Obstructive Jaundice (A):** In complete biliary obstruction, bile cannot reach the intestine. Since urobilinogen is formed by bacterial action on bilirubin in the gut, no urobilinogen is produced. Thus, urobilinogen is **absent** in urine (and stools are clay-colored). * **Hepatic Fibrosis (B) & Fatty Liver (C):** While these represent chronic liver changes, they do not typically present with the acute, significant hyperbilirubinemia and the specific "leakage" of urobilinogen seen in acute inflammatory states like hepatitis. **High-Yield Clinical Pearls for NEET-PG:** * **Hemolytic Jaundice:** Characterized by elevated Unconjugated Bilirubin and **increased** urinary urobilinogen (due to overproduction). * **Hepatocellular Jaundice:** Elevated Conjugated & Unconjugated Bilirubin; **increased** urinary urobilinogen. * **Obstructive Jaundice:** Elevated Conjugated Bilirubin; **absent** urinary urobilinogen; presence of bile salts in urine (Hay’s Test positive). * **Van den Bergh Reaction:** Indirect positive in Hemolytic; Direct positive in Obstructive; Biphasic in Hepatocellular jaundice.

Question 190: All of the following are normal average values of urine, except?

A. Albumin to Globulin ratio = 4:1 (Correct Answer)
B. Serum potassium 4.5-6 mg/100 ml
C. Serum alkaline phosphatase 1.5-5 Bodansky units
D. None of the above

Explanation: **Explanation:** The correct answer is **A (Albumin to Globulin ratio = 4:1)** because this value is incorrect for human serum. In a healthy individual, the normal **Albumin to Globulin (A:G) ratio is approximately 1.2:1 to 2:1**. * **Why Option A is correct (the exception):** The normal serum albumin range is 3.5–5.0 g/dL, and globulin is 2.0–3.5 g/dL. A ratio of 4:1 is abnormally high and does not represent a "normal average value." A reversed A:G ratio (where globulin exceeds albumin) is clinically significant and seen in conditions like chronic liver disease (cirrhosis), multiple myeloma, and chronic inflammation. * **Why Option B is incorrect:** Serum potassium levels are typically reported as 3.5–5.0 mEq/L. When converted to mg/100 ml (mg/dL), the value is approximately **4.5–6 mg/dL** (since 1 mEq of K+ = 39 mg). Thus, this is a normal physiological value. * **Why Option C is incorrect:** The **Bodansky unit** is an older unit for measuring Alkaline Phosphatase (ALP). The normal range is indeed **1.5–5 Bodansky units/dL** in adults. (Note: In modern SI units, the range is 30–120 U/L). **NEET-PG High-Yield Pearls:** * **Reversed A:G Ratio:** Always suspect **Cirrhosis** (decreased albumin synthesis) or **Multiple Myeloma** (increased monoclonal globulins). * **Hyperkalemia:** Defined as serum K+ > 5.0 mEq/L; it is a medical emergency due to the risk of cardiac arrhythmias (Tall T-waves on ECG). * **ALP Markers:** Elevated ALP is a hallmark of **cholestatic jaundice** and **bone diseases** (like Paget’s disease or rickets) where there is increased osteoblastic activity.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free